Hutchison China Meditech Limited Director's Share Dealing (6335O)
August 22 2017 - 4:00AM
UK Regulatory
TIDMHCM
RNS Number : 6335O
Hutchison China Meditech Limited
22 August 2017
Director's Share Dealing
London: Tuesday, August 22, 2017: Hutchison China MediTech
Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications
that Ms Edith Shih, Non-executive Director and Company Secretary,
purchased a total of 4,000 American Depositary Shares of the
Company ("ADSs", each representing one half of one ordinary share
of US$1.00 each in the capital of Chi-Med) at an average price of
US$24.99 per ADS on August 18 and 21, 2017.
Following the above purchases, Ms Shih is interested in 100,000
ADSs and 70,000 Ordinary Shares, representing approximately 0.20%
of the current issued share capital of Chi-Med.
The notification set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Ms Edith Shih
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Non-executive Director and Company Secretary
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial ADS each representing one half of one Ordinary Share of US$1.00
instrument, type of instrument ADS ISIN: US44842L1035
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 4,000 ADSs on August 18 and 21, 2017 at an average price
of US$24.99 per ADS.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
US$25.00 3,569
------------------------------------------------------------------------------- -----------------------------------
US$24.98 100
------------------------------------------------------------------------------- -----------------------------------
US$24.99 100
------------------------------------------------------------------------------- -----------------------------------
US$24.91 200
------------------------------------------------------------------------------- -----------------------------------
US$24.92 31
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information Aggregated volume: 4,000 ADSs
- Aggregated volume Price information: US$24.99
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-18 - acquisition of 3,769 ADSs
2017-08-21 - acquisition of 231 ADSs
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
----- ------------------------------------ -------------------------------------------------------------------------
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited ("CK Hutchison") (SEHK: 0001). For more
information, please visit: www.chi-med.com.
CONTACTS
Investor Enquiries
Mark Lee,
SVP Corporate Finance & Development +852 2121 8200
U.K. & International Media Enquiries
Anthony Carlisle, Citigate Dewe Rogerson +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk
U.S. Based Media Enquiries
Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com
Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com
Investor Relations
Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com
David Dible, Citigate Dewe Rogerson +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFEDTIIFFID
(END) Dow Jones Newswires
August 22, 2017 04:00 ET (08:00 GMT)
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Apr 2023 to Apr 2024